Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Psychiatry/Psychology
Disease Category: Psychosis
Trial Information
A Placebo-Controlled Study of Metformin Effectiveness in Counteracting Insulin Resistance and Weight Gain in Patients Treated with Clozapine and Olanzapine.
This research study is examining the effects of a medication
called metformin (Glucophage) on weight gain associated with the
antipsychotic medications clozapine (Clozaril) and
olanzapine(Zyprexa). The aim of this study is to investigate if
adding metformin to participants current medication regimen can
stop them from gaining weight, or even allow them to lose
weight.
This is a 12 month study. If eligible to participate in this
research study, participants will receive research study medication
and treatment at no charge. Transportation reimbursement will also
be provided at the request of the participant.
For a detailed description of this study or to schedule an
appointment please contact the study coordinator, Carine Jean-Louis
at (212) 659-8795
No Compensation Provided
Patient Inclusion/Exclusion Criteria:
This research study is open to individuals between the ages of
18-55 years old that are taking the antipsychotic medication
clozapine (Clozaril) or olanzapine (Zyprexa)and have gained weight
because of these medications but are otherwise in good health.
Females who are pregnant or nursing and individuals with a
serious or unstable medical condition will not be eligible to
participate in this research study.
Carine Jean-Louis, Clinical Research Coordinator
Mount Sinai Medical Center
One Gustave L. Levy Place
New York NY 10029
Phone: (212) 659-8795
Fax: (212) 831-1844
EMail: carine.jean-louis@mssm.edu
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
